Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up 18F-AV-1451 Scan in Alzheimer's Disease
NCT02795780Phase 2Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Avid Radiopharmaceuticals. Primary endpoint: Change in Tau Deposition Over Time by Diagnostic Group and Amyloid Status at 18 months. Started Aug 2016; status: completed.
Beyond the preview
Go deeper on NCT02795780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02795780.